UB Paderborn / Katalog / Suche / in CDI

Sex-Specific Multiparameter Blood Test for the Early Diagnosis of Alzheimer's Disease

International journal of molecular sciences, 2022-12, Vol.23 (24), p.15670

2022

Link zum Volltext

Verfügbarkeit prüfen

Curcumin reduces alpha-synuclein induced cytotoxicity in Parkinson's disease cell model

BMC neuroscience, 2010-04, Vol.11 (1), p.57-57, Article 57

2010

Link zum Volltext

Verfügbarkeit prüfen

Trehalose differentially inhibits aggregation and neurotoxicity of beta-amyloid 40 and 42

Neurobiology of disease, 2005-10, Vol.20 (1), p.74-81

2005

Link zum Volltext

Verfügbarkeit prüfen

A conformation-specific antibody against oligomeric β-amyloid restores neuronal integrity in a mouse model of Alzheimer's disease

The Journal of biological chemistry, 2021-01, Vol.296, p.100241, Article 100241

2021

Link zum Volltext

Verfügbarkeit prüfen

Physico-chemical determinants of soluble intrabody expression in mammalian cell cytoplasm

Protein engineering, design and selection, 2010-06, Vol.23 (6), p.489-498

2010

Link zum Volltext

Verfügbarkeit prüfen

Intracellular targeting and clearance of oligomeric alpha-synuclein alleviates toxicity in mammalian cells

Neuroscience letters, 2009-07, Vol.459 (1), p.16-18

2009

Link zum Volltext

Verfügbarkeit prüfen

Human α4β2 nicotinic acetylcholine receptor as a novel target of oligomeric α-synuclein

PloS one, 2013-02, Vol.8 (2), p.e55886

2013

Link zum Volltext

Verfügbarkeit prüfen

Oligomeric α-synuclein and β-amyloid variants as potential biomarkers for Parkinson's and Alzheimer's diseases

The European journal of neuroscience, 2016-01, Vol.43 (1), p.3-16

2016

Link zum Volltext

Verfügbarkeit prüfen

Toxic Oligomeric Alpha-Synuclein Variants Present in Human Parkinson's Disease Brains Are Differentially Generated in Mammalian Cell Models

Biomolecules (Basel, Switzerland), 2015-07, Vol.5 (3), p.1634-1651

2015

Link zum Volltext

Verfügbarkeit prüfen

Soluble α-synuclein-antibody complexes activate the NLRP3 inflammasome in hiPSC-derived microglia

Proceedings of the National Academy of Sciences - PNAS, 2021-04, Vol.118 (15), p.e2025847118

2021

Link zum Volltext

Verfügbarkeit prüfen

A novel nicotinic mechanism underlies β-amyloid-induced neurotoxicity

Neuropharmacology, 2015-10, Vol.97, p.457-463

2015

Link zum Volltext

Verfügbarkeit prüfen

Bispecific Antibody Fragment Targeting APP and Inducing α-Site Cleavage Restores Neuronal Health in an Alzheimer’s Mouse Model

Molecular neurobiology, 2019-11, Vol.56 (11), p.7420-7432

2019

Link zum Volltext

Verfügbarkeit prüfen

Inhibiting β-Secretase Activity in Alzheimer's Disease Cell Models with Single-Chain Antibodies Specifically Targeting APP

Journal of molecular biology, 2011-01, Vol.405 (2), p.436-447

2011

Link zum Volltext

Verfügbarkeit prüfen

CNS disease-related protein variants as blood-based biomarkers in traumatic brain injury

Neurology, 2018-10, Vol.91 (15), p.702

2018

Link zum Volltext

Verfügbarkeit prüfen

Detecting Morphologically Distinct Oligomeric Forms of α-Synuclein

The Journal of biological chemistry, 2009-04, Vol.284 (17), p.11048-11058

2009

Link zum Volltext

Verfügbarkeit prüfen

CSF levels of oligomeric alpha-synuclein and beta-amyloid as biomarkers for neurodegenerative disease

Integrative biology (Cambridge), 2011-12, Vol.3 (12), p.1188-1196

2011

Link zum Volltext

Verfügbarkeit prüfen

Isolation and characterization of antibody fragments selective for toxic oligomeric tau

Neurobiology of aging, 2015-03, Vol.36 (3), p.1342-1355

2015

Link zum Volltext

Verfügbarkeit prüfen

Blood-Based Oligomeric and Other Protein Variant Biomarkers to Facilitate Pre-Symptomatic Diagnosis and Staging of Alzheimer's Disease

Journal of Alzheimer's disease, 2017-01, Vol.58 (1), p.23

2017

Link zum Volltext

Verfügbarkeit prüfen

Isolation of a Human Single Chain Antibody Fragment Against Oligomeric α-Synuclein that Inhibits Aggregation and Prevents α-Synuclein-induced Toxicity

Journal of molecular biology, 2007-05, Vol.368 (4), p.1132-1144

2007

Link zum Volltext

Verfügbarkeit prüfen

TDP-43 protein variants as biomarkers in amyotrophic lateral sclerosis

BMC neuroscience, 2017-01, Vol.18 (1), p.20-20, Article 20

2017

Link zum Volltext

Verfügbarkeit prüfen

Nanobody specific for oligomeric beta-amyloid stabilizes nontoxic form

Neurobiology of aging, 2012-07, Vol.33 (7), p.1320-1328

2012

Link zum Volltext

Verfügbarkeit prüfen

Residues 17-20 and 30-35 of beta-amyloid play critical roles in aggregation

Journal of neuroscience research, 2004-01, Vol.75 (2), p.162-171

2004

Link zum Volltext

Verfügbarkeit prüfen

Isolation and characterization of antibody fragments selective for specific protein morphologies from nanogram antigen samples

Biotechnology progress, 2013-03, Vol.29 (2), p.463-471

2013

Link zum Volltext

Verfügbarkeit prüfen

A Human Single-Chain Fv Intrabody Blocks Aberrant Cellular Effects of Overexpressed α-Synuclein

Molecular therapy, 2004-12, Vol.10 (6), p.1023-1031

2004

Link zum Volltext

Verfügbarkeit prüfen

Cyclodextrins promote protein aggregation posing risks for therapeutic applications

Biochemical and biophysical research communications, 2009-08, Vol.386 (3), p.526-531

2009

Link zum Volltext

Verfügbarkeit prüfen

Menü

Weitere Dienste

Einstellungen

Sex-Specific Multiparameter Blood Test for the Early Diagnosis of Alzheimer's Disease

Curcumin reduces alpha-synuclein induced cytotoxicity in Parkinson's disease cell model

Trehalose differentially inhibits aggregation and neurotoxicity of beta-amyloid 40 and 42

A conformation-specific antibody against oligomeric β-amyloid restores neuronal integrity in a mouse model of Alzheimer's disease

Physico-chemical determinants of soluble intrabody expression in mammalian cell cytoplasm

Intracellular targeting and clearance of oligomeric alpha-synuclein alleviates toxicity in mammalian cells

Human α4β2 nicotinic acetylcholine receptor as a novel target of oligomeric α-synuclein

Oligomeric α-synuclein and β-amyloid variants as potential biomarkers for Parkinson's and Alzheimer's diseases

Toxic Oligomeric Alpha-Synuclein Variants Present in Human Parkinson's Disease Brains Are Differentially Generated in Mammalian Cell Models

Soluble α-synuclein-antibody complexes activate the NLRP3 inflammasome in hiPSC-derived microglia

A novel nicotinic mechanism underlies β-amyloid-induced neurotoxicity

Bispecific Antibody Fragment Targeting APP and Inducing α-Site Cleavage Restores Neuronal Health in an Alzheimer’s Mouse Model

Inhibiting β-Secretase Activity in Alzheimer's Disease Cell Models with Single-Chain Antibodies Specifically Targeting APP

CNS disease-related protein variants as blood-based biomarkers in traumatic brain injury

Detecting Morphologically Distinct Oligomeric Forms of α-Synuclein

CSF levels of oligomeric alpha-synuclein and beta-amyloid as biomarkers for neurodegenerative disease

Isolation and characterization of antibody fragments selective for toxic oligomeric tau

Blood-Based Oligomeric and Other Protein Variant Biomarkers to Facilitate Pre-Symptomatic Diagnosis and Staging of Alzheimer's Disease

Isolation of a Human Single Chain Antibody Fragment Against Oligomeric α-Synuclein that Inhibits Aggregation and Prevents α-Synuclein-induced Toxicity

TDP-43 protein variants as biomarkers in amyotrophic lateral sclerosis

Nanobody specific for oligomeric beta-amyloid stabilizes nontoxic form

Residues 17-20 and 30-35 of beta-amyloid play critical roles in aggregation

Isolation and characterization of antibody fragments selective for specific protein morphologies from nanogram antigen samples

A Human Single-Chain Fv Intrabody Blocks Aberrant Cellular Effects of Overexpressed α-Synuclein

Cyclodextrins promote protein aggregation posing risks for therapeutic applications

Aktive Filter

Suchergebnisse filtern